Hester Biosciences Ltd.

NSE: HESTERBIO | BSE: 524669 | ISIN: INE782E01017 | Industry: Pharmaceuticals
| Expensive Performer
1940.5000 4.20 (0.22%)
NSE Apr 25, 2025 15:31 PM
Volume: 35,323
 

1940.50
0.22%
Karvy
Domestic Brucella and PPR Vaccines Sales Drive Profitability: A surprise and significant jump in domestic Large Animal Vaccines (LAV) sales - primarily Brucella vaccine and to smaller degree PPR vaccines - have led to considerableexpansion in gross margin and EBITDA margin.
Hester Biosciences Ltd. is trading below its 100 day SMA of 1943.6
More from Hester Biosciences Ltd.
Recommended